Prostanoids are bioactive substances that contribute to various biological and pathological processes. To evaluate both extracellular and intracellular levels of prostanoids at the same time, we developed methods for quantification of extracellular and intracellular levels of prostanoids, including prostaglandin E 2 (PGE 2 ), PGD 2 , PGF 2α , 6-keto PGF 1α , and TXB 2 , in cultured cells using liquid chromatography/tandem mass spectrometry (LC/MS/MS), and we validated the LC/MS/MS methods. A solid-phase extraction cartridge was used for extraction of prostanoids. The prostanoids were separated by a C 18 column with an isocratic flow of acetonitrile/water/acetic acid 
Introduction
Prostanoids, including prostaglandins and thromboxane, are important bioactive lipid mediators of various physiological and pathological processes [1] [2] [3] [4] . For example, prostaglandin E 2 (PGE 2 ) is involved in inflammation, carcinogenesis, and immune modulation. Prostaglandin D 2 (PGD 2 ) also contributes to inflammation and immune modulation and is involved in induction of sleep. Prostaglandin F 2α (PGF 2α ) contributes to induction of parturition and contraction of smooth muscle. Furthermore, prostaglandin I 2 (PGI 2 ) has platelet anti-aggregating and vascular dilation effects. On the other hand, thromboxane A 2 (TXA 2 ) has platelet aggregation and vascular contraction effects. Since PGI 2 and TXA 2 have short half-life periods, they are non-enzymatically converted into 6-keto prostaglandin F 1α ) and TXB 2 , respectively. Prostanoids are biosynthesized from arachidonic acid via the arachidonic acid cascade. Arachidonic acid is released from the cell membrane into the cytoplasm by phospholipase A 2 and then converted into PGH 2 by cyclooxygenase (COX-1 and COX-2). PGH 2 is further converted into PGE 2 , PGD 2 , PGF 2α , PGI 2, and TXA 2 by each prostaglandin synthase. Prostanoids are secreted from the intracellular space into the extracellular space by a specific transport system and exert their biological effects in an autocrine or paracrine manner by binding to cell surface receptors. In addition to prostanoids synthesis, transport and inactivation mechanisms are thought to be important for controlling extracellular levels of prostanoids [1] . Therefore, in addition to extracellular levels of prostanoids, examination of intracellular profiles of prostanoids is important for understanding the mechanism for control of prostanoid secretion and signaling. cartridges (100 mg/1 mL) were obtained from Agilent Technologies (Santa Clara, CA).
LC/MS/MS
Chromatographic separation was carried out using a Shimadzu Prominance 20A System (Shimadzu, Kyoto, Japan). A Shiseido CAPCELL PAK C18 MGII column Table 1 . Data were acquired and analyzed using Analyst software (version 1.5) (Applied Biosystems). Calibration curves were constructed by plotting peak area ratio (standard to internal standard) versus the nominal concentration and were fit using least-squares regression with 1/x weighting. 
Standards and calibration curve preparation for LC/MS/MS analysis

Cell culture
Human lung adenocarcinoma epithelial A549 cells were kept in Dulbecco's modified Eagle's medium (Sigma) with 10% fetal bovine serum (ICN Biomedicals, Inc, Aurora, OH) and 1% penicillin-streptomycin (Sigma). Human airway epithelial Calu-3 cells were kept in DMEM/F12 (Gibco/Invitrogen, Grand Island, NY) with 10% fetal bovine serum and 1% penicillin-streptomycin. All cells were grown at 37˚C under 5% CO 2 . A549 cells (2 × 10 5 cells/well) and Calu-3 cells (1 × 10 6 cells/well) were seeded on 6-well plastic plates (Corning Costar Corp., Cambridge, MA). After the cells had grown to confluence (4 days for A549 cells and typically 7 days for Calu-3 cells), they were incubated overnight in serum-free medium before each experiment. For induction of the production of prostanoids, cells were then treated with 1 mL of serum-free medium containing 10 µM A23187 for a designated time.
Sample preparation
For measurement of extracellular prostanoids, the medium was collected and 7 stored at -80°C until assay. The resulting cell monolayer was harvested for measurement of intracellular prostanoids. Sample preparation for extraction of intracellular prostanoids was based on the method of Lin et al. with modification [6] .
Briefly, cells were rinsed twice with ice-cold PBS and scraped into ice-cold PBS. The cell suspension was centrifuged at 1,500×g for 5 min at 4°C and the resulting pellet was stored at -80°C until assay.
Solid-phase extraction of prostnoids
The solid-phase extraction (SPE) cartridge Bond Elut ® C18 (100 mg/1 mL) (Agilent Technologies) was used for extraction of prostanoids. For extracellular assay, to each 500-µL sample of culture medium, 5 µL of a mixture of deuterated prostanoids (500 ng/mL each) as internal standards and 5 µL of 10% dibutylhydroxytoluene (BHT)
in ethanol for preventing peroxidation were added. For intracellular assay, to each frozen cell pellet (described above), 5 µL of a mixture of deuterated prostanoids and 5 µL of 10% BHT were added and suspended in 0.5 mL of 0.1 M phosphate buffer (pH 7.4, containing 1 mM EDTA and 10 µM indomethacin). The suspension was then sonicated for 30 sec at 4°C and centrifuged at 15,000×g for 15 min at 4°C. The supernatant was used for measurement of intracellular prostanoids. The sample was adjusted to pH 3 with 1 M HCl. Then the sample was added to the SPE cartridge, which was preconditioned with 1 mL of methanol, 1 mL of water, and then 1 mL of water (pH 3). After the sample had been loaded, the cartridge was washed with 1 mL of water and then with 1 mL of methanol/water (3:7, v/v). Then prostanoids were eluted with 1 mL of methanol. The eluate was dried under a nitrogen gas stream at 25°C and the residue was reconstituted in 50 µL of mobile phase. (for intracellular measurement), extracting as described above, and comparing with unextracted standards that represent 100% recovery. For evaluation of short-term stability of prostanoids in medium, we measured remaining amounts after addition of prostanoids to the medium at two concentrations (5 and 50 ng/mL) at room temperature or 4°C. For evaluation of long-term stability, we measured remaining amounts after storing prostanoids in medium (for extracellular measurement) or in Calu-3 cell pellets (for intracellular measurement) at two concentrations (2.5 and 25 ng) at -80°C.
Results and discussion
LC/MS/MS
Negative ion full-scan mass spectra (Q1) of prostanoids and internal standards Table 1 . The isomers PGE 2 and PGD 2 showed similar fragmentation patterns, indicating that chromatographic separation is required for accurate quantification. A Shiseido CAPCELL PAK C18 MGII column was used for chromatographic separation. We investigated several mobile phase conditions such as pH and organic solvents for simultaneous quantification of the five prostanoids.
When the mobile phase methanol or acetonitrile in ammonium acetate buffer (pH 8)
was investigated, the peak of 6-keto PGF 1α was very low and broad. On the other hand, use of acetonitrile in acidic conditions produced optimal separation with a high degree of sensitivity of all prostanoids. Finally, optimal separation with a high degree of sensitivity was obtained using acetonitrile/water/acetic acid (40:60:0.1, v/v/v) (Fig. 2) .
The isomers PGE 2 and PGD 2 were separated by approximately 1 min (resolution Rs = 3.2). In comparison with previous studies, the separation efficiency was good despite simple isocratic separation and the run time was short (12 min) [7, 15] . 
Calibration curve
For extracellular measurement, calibration standards were prepared in blank medium. For intracellular measurement, calibration standards were prepared in phosphate buffer, the composition of which is described in the Materials and methods section, because cells contain several prostanoids endogenously. As shown in Table 2 , calibration curves of the prostanoids for extracellular measurement were linear in the range from 0.1 to 100 ng/mL (r 2 > 0.999), and those for intracellular measurement were linear in the range from 0.05 to 50 ng (r 2 > 0.999).
Recovery
A Bond Elut ® C18 disk cartridge was used for extraction of prostanoids. Our extraction procedure produced excellent clean-up results. The recovery from blank medium was measured by spiking known amounts of prostanoids at three different concentrations (0.5, 5, and 50 ng/mL) into blank medium and comparing the mean peak area ratio with unextracted standards that represent 100% recovery. Since the cells contain the prostanoids endogenously, the recovery from Calu-3 cell pellets was calculated as [(area ratio of extracted sample -area ratio of blank sample)/area ratio of unextracted standards] × 100 (%). The recovery from medium ranged from 74.4 to 91.1% and that from Calu-3 cells ranged from 74.7 to 84.1%. The results are summarized in Table 3 .
Accuracy and precision
The intra-day precision and inter-day precision as well as accuracy were tested 11 at three different concentrations (0.5, 5, and 50 ng/mL for extracellular measurement and 0.25, 2.5, and 5 ng for intracellular measurement). For the extracellular assay, the intra-day precision ranged from 2.3 to 6.5% and the relative errors were -4.1 to 5.9%.
The inter-day precision ranged from 3.2 to 6.8% and the relative errors were -1.2 to 4.5% (Table 4 ). For intracellular assay validation, we used Calu-3 cells and A549 cells.
Calu-3 and A549 cells endogenously contain PGE 2 , PGF 2α , and TXB 2 . However, the amounts of prostanoids in Calu-3 validation samples were smaller than the lower limit of quantification (LLOQ). LLOQ was defined as signal-to-noise (S/N) ratio of > 10.
The intra-day precision ranged from 2.2 to 5.7% and relative errors were -5.8 to 2.3%.
The inter-day precision ranged from 3.4 to 13.3% and relative errors were -1.2 to 7.3 % (Table 5 , left). On the other hand, a large amount of PGE 2 was detected in A549 cells.
Although there were detectable levels of PGF 2α and TXB 2 , these amounts of validation samples were less than the LLOQ. The intra-day precision ranged from 1.2 to 9.7% and relative errors were -3.5 to 14.9%. The inter-day precision ranged from 1.6 to 13.7%
and relative errors were -1.0 to 10.1% (Table 5 , right). These results indicate that the method of intracellular measurement is highly reliable with good accuracy and precision.
Stability
We examined the stability of prostanoids in cell culture medium or in cell samples. For evaluation of short-term stability of the prostanoids in medium, we measured remaining amounts after addition of prostanoids to the medium at two concentrations (5 and 50 ng/mL). All prostanoids in the medium were stable for at least 4 hours at room temperature, and all of the prostanoids expect for PGD 2 were stable at 12 24 hours (Table 6A ). The remaining PGD 2 in the medium was less than 50% at 24 hours.
Instability of PGD 2 was reported previously [7] . However, PGD2 was more stable at 4°C than at room temperature. For evaluation of long-term stability, we measured remaining amounts after storing prostanoids in medium (for extracellular measurement) or in Calu-3 cell pellets (for intracellular measurement) at two concentrations (5 and 50 ng/mL for extracellular measurement, 2.5 ng and 25 ng for intracellular measurement)
at -80°C (Table 6B ). The results indicated that all prostanoids both in the medium and in
Calu-3 cells were stable for at least 4 weeks at -80°C.
Intracellular and extracellular prostanoids in Calu-3 and A549 cells
To test the suitability of the method, we measured prostanoids produced by Calu-3 cells or A549 cells under the condition of stimulation by the calcium ionophore A23187 (10 µM). In A549 cells, the levels of PGE 2 , PGF 2α and TXB 2 were larger than LLOQ both in extracellular and intracellular compartments under a non-stimulated condition ( Fig. 3A and 3B) . The results showing that A549 cells mainly secreted PGE 2 , PGF 2α and TXB 2 were in agreement with the report by Hubbard et al. [21] . In Table 5 , intracellular levels of PGF 2α and TXB 2 were smaller than LLOQ. However, the levels of PGF 2α and TXB 2 under a non-stimulated condition were slightly larger than LLOQ in Fig. 3 . Although the levels of PGF 2α and TXB 2 were larger than LLOQ in Fig. 3 , those were close to LLOQ. Furthermore, the passage number of A549 cells used in Fig. 3 was different from that in Table 5 . Consequently, the endogenous levels of prostanoids might be slightly different between the samples of Table 5 and those of Fig.3 . A23187 treatment further increased extracellular levels of these prostanoids, peaking within 5
min at approximately 12 ng/mL (34 nM) for PGE 2 , 5 ng/mL (14 nM) for PGF 2α , and 0.8 13 ng/mL (2.2 nM) for TXB 2 ( Fig. 3A and 3B ). Considering affinities of receptors, the concentrations of these prostanoids in the extracellular space were reasonable [22] . On the other hand, the change in intracellular levels by A23187 was moderate in comparison to the change in extracellular levels. The results indicate the possibility that export of the prostanoids is very rapid. In Calu-3 cells, amounts of all prostanoids were smaller than the LLOQ under the non-stimulated condition both in the extracellular and intracellular compartments. A23187 treatment increased extracellular PGE 2 , PGF 2α and TXB 2 levels, peaking at 15-30 min ( Fig. 4A and 4B ). The results showing that Calu-3 mainly secreted PGE 2 , PGF 2α and TXB 2 were also in agreement with the report by
Hubbard et al. [19] . The differences between levels of prostanoids produced in A549 cells and Calu-3 cells may be caused by the expression level of COX-2. The expression level of COX-2 in A549 cells was higher than that in Calu-3 cells (data not shown).
A23187 also increased intracellular PGE 2 , PGF 2α and TXB 2 levels. Interestingly, it seemed that intracellular PGF 2α level relative to extracellular level was lower than those of other prostanoids, PGE 2 and TXB 2, both in Calu-3 cells and A549 cells. The differences might be due to differences in membrane permeability among these prostanoids. Further investigations to clarify the hypothesis are in progress, and we need to accumulate more information on intracellular levels of the prostanoids by examination of various other cell lines. Furthermore, we need to clarify the reason why the change in intracellular levels of prostanoids was moderate in comparison to the change in extracellular levels.
Conclusion
We developed a method for simultaneous quantification of the intracellular 14 levels of five major prostanoids, PGE 2 , PGD 2 , PGF 2α , 6-keto PGF 1α and TXB 2 , in cultured cells using LC/MS/MS in addition to a method for extracellular measurement. and TXB 2 by stimulation with A23187. 
